238 related articles for article (PubMed ID: 211546)
1. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
Azuma I; Yamamura Y
Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
[No Abstract] [Full Text] [Related]
2. [Immunochemistry of tubercle bacilli, with special reference to adjuvant activity (author's transl)].
Azuma I
Kekkaku; 1981 Dec; 56(12):595-607. PubMed ID: 7035731
[No Abstract] [Full Text] [Related]
3. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
4. [Action mechanism of cell wall skeleton of BCG and Nocardia rubra as immunomodulator].
Ogura T; Yoshimoto T; Sakatani M; Nishikawa H; Masuno T; Kawase I; Namba M; Hirao F; Yamamura Y; Itoh M
Nihon Rinsho; 1981 Apr; 39(4):1852-60. PubMed ID: 7031297
[No Abstract] [Full Text] [Related]
5. [Immunotherapy of cancer with BCG].
Yamamura Y; Azuma I
Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
[No Abstract] [Full Text] [Related]
6. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of lung cancer using BCG cell-wall skeleton].
Yasumoto K
Kekkaku; 1977 Oct; 52(10):530-1. PubMed ID: 340747
[No Abstract] [Full Text] [Related]
8. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
[TBL] [Abstract][Full Text] [Related]
9. [Immunity against cancer--a critical review of recent progress--].
Yamamura Y
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):311-9. PubMed ID: 6192758
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
[TBL] [Abstract][Full Text] [Related]
11. [Symposium on cancer and immunity. (6) Prospect of tumor immunotherapy (author's transl)].
Yamamura Y
Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1512-3. PubMed ID: 744894
[No Abstract] [Full Text] [Related]
12. Nonspecific immunotherapy of malignant tumors.
Milas L; Withers HR
Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
[TBL] [Abstract][Full Text] [Related]
13. Immunological adjuvants in cancer immunotherapy.
Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
[No Abstract] [Full Text] [Related]
14. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
15. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
[No Abstract] [Full Text] [Related]
16. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
17. Effect of isoniazid on BCG-mediated tumor immunity.
Romolo JL; Loyd B; Cohen MH
Surg Forum; 1977; 28():158-9. PubMed ID: 364713
[No Abstract] [Full Text] [Related]
18. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy].
Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H
Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535
[No Abstract] [Full Text] [Related]
19. [Immunotherapy and immunochemotherapy of neoplasms-- present status and prospects].
Saijo N; Niitani H
Nihon Rinsho; 1981 Apr; 39(4):1874-92. PubMed ID: 6273609
[No Abstract] [Full Text] [Related]
20. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
